Pharmacotherapy Review 2022: Overweight and Obesity
Pharmacotherapy Review 2022: Overweight and Obesity is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.
Published: August 13, 2021
Expires: August 13, 2024
Goal:
To provide a summary of emerging data on the treatment of overweight and obesity and the limitations of available research on pathogenesis of these conditions, special populations affected by them, and their nonpharmacologic and pharmacologic management.
Educational Objectives:
Upon completion of this program, participants should be better able to:
• Identify endogenous mechanisms and exogenous influences on the development of dysfunctional energy homeostasis and obesity
• Given a list of patients select those that meet criteria for pharmacotherapy for weight loss
• For a selected weight loss medication, identify the recommended dose, common adverse effects, and monitoring parameters for use
• Given a patient medication history, identify agents with potential to cause weight gain
Additional details will be posted as soon as information is available.